Webinar | Nestlé and Arla are leading GLP-1 food innovation. Is your R&D keeping up?​ Register Now

KinCon biolabs

KinCon Biolabs develops kinase activity biosensors for drug development and cellular reaction tracking.
2022
1-10
Innsbruck, Tirol, Austria
  • Bioanalytical Devices
  • Drug Discovery and Development
  • Personalized Medicine Technologies

Investment Funding

Revenue

$1M to $10M

Something missing or incorrect on this page? Help us enrich this information